Mira Pharmaceuticals Inc (MIRA) Stock Price

0.9175 ▲ +0.0071 (+0.78%)
Open: 0.9132 Vol: 0 Day's range: 0.9063 - 0.9175 Jun 25, 12:33 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
MIRA Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 0.92▼ 0.93▼ 0.93▼ 0.94▼ 0.97▼
MA10 0.94▼ 0.94▼ 0.94▼ 0.94▼ 0.99▼
MA20 0.95▼ 0.95▼ 0.95▼ 0.99▼ 1.05▼
MA50 0.96▼ 0.97▼ 0.97▼ 1.01▼ 1.29▼
MA100 1.00▼ 1.00▼ 0.99▼ 1.08▼ 1.29▼
MA200 1.01▼ 1.01▼ 1.02▼ 1.26▼ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD -0.005▼ -0.004▼ -0.003▼ -0.006▼ -0.002▼
RSI 35.041▼ 36.496▼ 36.840▼ 39.679▼ 38.729▼
STOCH 6.744▼ 10.315▼ 10.315▼ 22.330     20.727    
WILL %R -80.920▼ -82.848▼ -82.848▼ -91.617▼ -96.187▼
CCI -111.178▼ -156.974▼ -156.974▼ -163.040▼ -141.748▼
Latest Filters Detected On MIRA
CDL $MIRA Hammer Candlestick Pattern Detected Set Alert
CDL $MIRA Harami Candlestick Pattern Detected Set Alert
Mira Pharmaceuticals Inc News
MIRA Pharmaceuticals Stock Surges Following Positive Preclinical Data
Thursday, October 16, 2025 07:16 AM
MIRA Pharmaceuticals Inc (NASDAQ:MIRA) shares are trading significantly higher on Thursday following the announcement of new preclinical data for its lead candidate Mira-55. What Happened: MIRA ...
MIRA Pharmaceuticals Announces Completion of Phase 1 Single Ascending Dose for Oral Ketamir-2 with No Safety Concerns, Advances to Multiple Ascending Dose Stage
Tuesday, August 19, 2025 05:30 AM
Following FDA IND clearance for neuropathic pain, the Company is preparing to initiate its U.S. Phase 2a trial in Q4 2025 MIAMI, FL / ACCESS Newswire / August 19, 2025 / MIRA Pharmaceuticals, Inc.
MIRA Pharmaceuticals’ Second Ketamir-2 Manuscript Accepted for Peer-Reviewed Publication Demonstrating Superior Efficacy in Preclinical Neuropathic Pain Models Versus ...
Wednesday, August 13, 2025 10:41 AM
Manuscript accepted for publication in Frontiers in Pharmacology, “Oral Administration of Ketamir-2, a Novel Ketamine Analog, Attenuates Neuropathic Pain in Rodent Models via Selective NMDA Antagonism ...
MIRA historical stock data
date open high low close volume
25/06/26 0.9132 0.9175 0.9063 0.9175 75,198
24/06/26 0.9665 0.9697 0.91 0.9104 57,142
23/06/26 0.9503 0.97 0.9501 0.954 18,667
22/06/26 0.97 0.97 0.9501 0.9515 126,133
18/06/26 0.96 0.974 0.9501 0.9524 69,412
17/06/26 0.97 0.9947 0.9586 0.9782 77,598
16/06/26 0.9501 0.9683 0.9327 0.95 133,322
15/06/26 0.9598 0.9804 0.9319 0.9319 84,098
12/06/26 0.9669 0.9792 0.9357 0.94 118,298
11/06/26 0.9644 0.99 0.96 0.96 53,387
Quote Details
52wk Low:0.90
52wk High:2.45
Vol:0
Avg Vol(3m):2.6M
1Y Chng:-40.42%
1M Chng:-5.51%
Add to Watch List
More Information
Index US Composite
Market Cap. 40.09M